Deferred Sales Trust (DST) for Business Sale: How It Works, Risks, and When to Use It

A Deferred Sales Trust can extend installment-sale tax deferral to cash deals where the buyer pays in full at closing — but the structure requires genuine trust independence, and the IRS scrutinizes it closely. Here's what to understand before engaging a DST promoter.

The core problem a Deferred Sales Trust solves

In a standard IRC § 453 installment sale, you defer gain recognition by actually receiving payments from the buyer in future years. That works when the buyer needs seller financing — but most business acquisitions above $5M involve buyers paying all cash at closing, funded by bank debt or equity. The buyer has no interest in paying you in installments. You want to defer your $8M capital gain. Direct installment treatment is off the table.

A Deferred Sales Trust is structured to solve exactly this gap: it creates an installment sale between you and an independent trust, while the trust simultaneously sells to the cash buyer. You receive installment payments from the trust over years; the trust holds and invests the full sale proceeds in the interim.

How the structure works

1. You sell your business interest to the trust — not to the buyer — in exchange for an installment note from the trust. The note amount equals the business's fair market value.
2. The trust sells to the buyer for cash. Because the trust purchased from you at fair market value, the trust's basis equals the sale price — no taxable gain to the trust on the buyer transaction.
3. The trust holds the full proceeds and invests them. The trust's investment portfolio generates returns that fund the installment payments owed to you.
4. You recognize gain as you receive principal payments from the trust. Each year's principal payment triggers gain recognition at your gross profit ratio — exactly as in any § 453 installment sale. Interest payments are always ordinary income, regardless of what the trust earns.

The result: your gain is spread across the years you receive payments — potentially 10, 15, or 20 years — even though the buyer paid cash at closing.

The § 453(i) recapture trap: still fully applies

This is the most important limitation before evaluating whether a DST makes sense for your deal. Under § 453(i), all depreciation recapture income is recognized in the year you sell to the trust — it cannot be deferred across installment payments.¹

• § 1245 recapture (equipment, machinery, vehicles, § 179-expensed assets): the full recaptured amount is ordinary income in the year of sale to the trust. No deferral, period.
• § 1250 recapture (real property): unrecaptured § 1250 gain at max 25% federal rate, also accelerated into year 1.
• Only the gain in excess of recapture gets installment treatment.

If you're selling a business with $3M of accumulated depreciation on equipment, you're recognizing $3M of ordinary income in the year of sale regardless of the trust structure. For businesses with significant depreciable assets — manufacturing, healthcare practices, transportation, construction — recapture can represent the majority of gain, and the DST benefit is correspondingly limited. Run this math before evaluating the structure.

The trust must be genuinely independent

The entire structure depends on the IRS treating your sale to the trust as a true arm's-length transaction rather than a conduit or step arrangement. If the IRS applies the step-transaction doctrine and collapses the two steps (you → trust → buyer) into one (you → buyer), your entire gain is taxable in the year of closing — plus potential penalties and interest on the underpayment.²

What "independent" requires in practice:

• The trustee cannot be a related person under § 267 or § 707(b). No family members, no entities you control, no business partners with shared economic interests.
• The trust must exercise genuine discretion over investment decisions. If you can direct trust investments or override the trustee, the IRS may treat the trust as your agent rather than an independent counterparty.
• The sale to the trust should not be contingent on the buyer transaction. A transfer that occurs immediately before a signed purchase agreement, with no other purpose, is vulnerable to step-transaction challenge on the ground that the two steps were pre-planned as a single transaction.
• The trust must have economic substance beyond tax deferral. A trust with no independent purpose other than holding your deferred tax liability is not a legitimate trust — it is a promoter arrangement.

The IRS has challenged DST arrangements on these grounds and prevailed in cases where trustee independence was lacking. Kitces Research has published detailed analysis of the risks and what distinguishes legitimate implementations from abusive ones.³ Selecting a reputable third-party trustee with a genuine, documented investment mandate is essential — not a formality.

AFR requirements on the trust note

The installment note the trust gives you must bear interest at at least the Applicable Federal Rate for the note's term. Below-AFR notes trigger IRS imputation of interest, meaning you're taxed on interest you never received while your basis is reduced accordingly.⁴

Current AFR rates for May 2026 (Rev. Rul. 2026-09):⁵

• Short-term (≤3 years): 3.82% annual
• Mid-term (3–9 years): 4.08% annual

Most DST payment schedules are structured as mid-term obligations. At 4.08% annual minimum, the trust's note to you carries a meaningful interest cost — all of which flows back to you as ordinary income, not capital gains.

Section 453A interest charge on large obligations

If your total outstanding installment obligations across all deals exceed $5 million at year-end, § 453A requires you to pay an annual interest charge to the IRS on the deferred tax.¹ This rate tracks the IRS underpayment rate (federal short-term AFR + 3%). For 2026, this is approximately 6%. On $10M of deferred installment obligations with, say, a 23.8% blended tax rate, you'd owe roughly $143,000 per year in § 453A interest — a meaningful drag on the net benefit of deferral.

Costs: what you actually pay

A DST carries substantially higher costs than a direct installment sale:

• Trust setup and drafting: typically $15,000–$35,000 in legal fees.
• Annual trustee and management fees: typically 1–2% of trust assets per year. On a $10M trust at 1.5%, that is $150,000 annually — every year until the note is paid off. Over 10 years, cumulative fees of $1.5M are common.
• Ongoing tax compliance: the trust files its own returns each year.

These costs must be weighed explicitly against the tax benefit of deferral. The break-even depends on: the size of the gain, your marginal rate in each payment year, the trust's investment return above fees, the § 453A interest charge, and how long you spread the payments. A fee-only advisor can model this — the promoter cannot, because the promoter's interest is in closing the sale of the trust structure.

DST vs. direct installment sale vs. CRT vs. QSBS

When DST can make sense

• The buyer is paying all cash and installment deferral is a priority. This is the primary use case. When there is no natural installment stream from the buyer, a DST creates one through the trust structure.
• The gain is large, you have minimal depreciable assets, and your post-sale income will drop substantially. Spreading $10M+ of capital gain across 15 years at lower annual income can reduce IRMAA surcharges, NIIT exposure, and state income tax peaks — not just marginal federal rates.
• You have no charitable intent and QSBS does not apply. If you're an S-corp or LLC seller who doesn't qualify for QSBS, and you prefer not to route proceeds through a charity, the CRT is not an option. A DST may be the only available deferral vehicle for a cash transaction.
• The net-present-value math clears the fee hurdle. A fee-only advisor who is not selling the trust structure can model this honestly. The promoter cannot.

When to avoid DST

• Heavily depreciated assets dominate your gain. If § 1245 recapture represents most of your taxable gain, the DST defers only the remainder — which may not justify 1–2% annual fees for a decade.
• You qualify for QSBS exclusion. If your C-corp stock gain falls within the $15M OBBBA exclusion cap, the federal gain is eliminated — deferral adds no benefit for the excluded portion. Only the gain above the cap warrants deferral planning.
• Short time horizon. If you'll need the assets within 3–5 years, cumulative trustee fees likely exceed the tax benefit of the deferral.
• The promoter can't explain the trust's independent economic purpose. If the pitch is entirely about tax deferral and the trustee's role is described as administrative rather than genuinely discretionary, the IRS risk is high. Walk away.

The specialist case

A DST is not a do-it-yourself structure. It is a high-stakes arrangement where correct implementation produces meaningful tax deferral, and incorrect implementation produces immediate gain recognition plus penalties and interest on the underpayment. The IRS has challenged and prevailed against DST arrangements where trust independence was inadequate — and those taxpayers paid all the tax they tried to defer, plus more.

A fee-only exit-planning advisor who has worked with DST trustees can model whether the economics justify the cost, vet the trustee's independence against the § 267 related-person rules, and coordinate with your tax attorney and CPA before the transaction closes. If you're within 24 months of a cash-buyer transaction and want to evaluate this option, that analysis should happen now — not after the LOI is signed.

Sources

1. IRC § 453 — Installment Method (LII / Cornell Law). § 453(i) accelerates depreciation recapture into year of sale; § 453A imposes annual interest charge on installment obligations exceeding $5M outstanding at year-end.
2. IRS Publication 537 — Installment Sales. Gross profit ratio calculation, gain recognition timing, and rules governing installment obligations and their disposition.
3. Kitces Research: Why a Deferred Sales Trust Can Be a Risky Way to Defer Taxes on a Business Sale. Detailed analysis of IRS step-transaction risk, what distinguishes legitimate DST implementations from abusive arrangements, and the economics of fee drag vs. deferral benefit.
4. IRC § 1274 — Determination of Issue Price in Case of Certain Debt Instruments Issued for Property (LII / Cornell Law). AFR minimum interest requirement; imputed interest rules on below-market installment notes.
5. Rev. Rul. 2026-09 — Applicable Federal Rates, May 2026. Short-term AFR 3.82%, mid-term AFR 4.08% (annual compounding); § 7520 rate 5.00%.
6. IRC § 267 — Losses, Expenses, and Interest Between Related Taxpayers (LII / Cornell Law). Related-person definition relevant to trustee independence requirement.

AFR and § 7520 rates verified against Rev. Rul. 2026-09 (May 2026). Recapture rules verified against IRC § 453(i) and IRS Pub. 537. Step-transaction risk analysis draws from Kitces Research and Oklahoma Bar Association analysis of DST structures. Always engage qualified tax counsel before implementing a DST — the IRS scrutiny risk is real and the consequences of collapse are severe.